Guy Chamberland

Guy Chamberland discloses dealings in Tetra Bio-Pharma Inc. to SEDI. Over a trading history stretching from 11 January 2017 to 29 June 2020, the count stands at 29 filings.

In open-market terms, that means 2 purchases worth €65k on one side and 21 sales worth €531k on the other. Taken together, the sales exceed the purchases by €466k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 option exercises. Since January 2020: 2 purchases and no sales on the market.

On 30 June 2020 came the latest disclosure, an open-market purchase for €13k in Tetra Bio-Pharma Inc. Typically, a trade is published a median of 2 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.